Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2014 Jan 1;55(1):97-104.
doi: 10.1093/jrr/rrt076. Epub 2013 May 31.

Assessment of anatomical and dosimetric changes by a deformable registration method during the course of intensity-modulated radiotherapy for nasopharyngeal carcinoma

Affiliations
Clinical Trial

Assessment of anatomical and dosimetric changes by a deformable registration method during the course of intensity-modulated radiotherapy for nasopharyngeal carcinoma

Jie Lu et al. J Radiat Res. .

Abstract

The aim of this study was to quantify the anatomic variations and the dosimetric effects accessed by a deformable registration method throughout the entire course of radiotherapy, and to evaluate the necessity of replanning for patients with nasopharyngeal carcinoma (NPC). Plan1(CT1) was based on the original CT, and Plan2(CT2) was generated from the midtreatment CT scan acquired after 25 fractions of IMRT of Plan1. Both sets of CTs, RT structures and RT doses for the two group plans were transferred to a workstation, and then a hybrid IMRT plan, Plan1(CT2), was generated by deforming doses of Plan1 to CT2. Subsequently, the accumulated plan, Plan1 + 2(CT2), was generated to quantify the actual dosimetric effects during the course. The transverse diameter of the neck at the center of the odontoid process was (15.4 ± 1.0) cm and (14.4 ± 1.1) cm in CT1 and CT2, respectively (P < 0.05). Compared with CT1, the mean volumes of the right and left parotid glands were significantly decreased by (24.6 ± 11.9)% and (35.1 ± 20.1)%, respectively. Comparison of Plan1 (CT1) with Plan1 (CT2) indicated that the doses to targets decreased without replanning. With repeated CT and replanning after 25 fractions, the doses to targets would be improved. The doses to normal tissue were increased without replanning. For eight patients out of 12, the doses to the spinal cord and brainstem exceeded the constraints without replanning, while the corresponding values decreased with replanning. During the entire course of IMRT, the volumes of the targets and the parotid glands would be reduced significantly. Midtreatment CT scanning and replanning are recommended to ensure adaptive doses to the targets and critical normal tissues.

Keywords: deformable registration; dosimetry; nasopharyngeal carcinoma; radiotherapy plan.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Measurement of transverse diameter at the center of odontoid process.
Fig. 2.
Fig. 2.
An example of the volumetric changes for the parotid glands between the first CT (CT1) and the second CT (CT2) images. Shown on images are right parotid contour (red) and left parotid contour (blue) for CT1, and right parotid contour (green) and left parotid contour (yellow) for CT2.
Fig. 3.
Fig. 3.
The dose distribution comparison of treatment planning during the course of IMRT. Plan 1(CT1) is the original plan based on the first CT scan; Plan2 (CT2) is the second IMRT with only the number of fractions used to complete the treatment based on the second CT; Plan1(CT2) is first IMRT plan deformed to the second CT scan; Plan1 + 2(CT2), representing the actual situation in which replanning would have occurred, is the accumulation of Plan1(CT1) and Plan2(CT2).

References

    1. Chen S-W, Yang S-N, Liang J-A, et al. Comparative dosimetric study of two strategies of intensity-modulated radiotherapy in nasopharyngeal cancer. Med Dosim. 2005;30:219–27. - PubMed
    1. Chung J-B, Lee J-W, Kim J-S, et al. Comparison of target coverage and dose to organs at risk between simultaneous integrated-boost whole-field intensity-modulated radiation therapy and junctioned intensity-modulated radiation therapy with a conventional radiotherapy field in treatment of nasopharyngeal carcinoma. Radiol Phys Technol. 2011;4:180–4. - PubMed
    1. Kam M, Chau R, Suen J, et al. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys. 2003;56:145–57. - PubMed
    1. Martin E, Deville C, Bonnetain F, et al. Intensity-modulated radiation therapy in head and neck cancer: prescribed dose, clinical challenges and results. Radiother Oncol. 2007;85:392–8. - PubMed
    1. Wong F-C, Ng A-W, Lee V-H, et al. Whole-field simultaneous integrated-boost intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2010;76:138–45. - PubMed

Publication types

MeSH terms